On May 1 in the journal Cell, MBI researchers published results from a first-ever human clinical trial of four adult patients using an mRNA cancer vaccine that quickly reprogrammed the immune system to attack glioblastoma, the most aggressive and lethal brain tumor.
Below, see a few examples of coverage this study received from top media outlets across the world:
Bloomberg: Scientist turns mRNA into cancer-fighting ‘onions’
First Coast News: Researchers at UF Health in Gainesville are one step closer to finding a cure for cancer
IFL Science: mRNA brain cancer vaccine shows promise in early trials in humans — and dogs
Live Science: New mRNA vaccine for deadly brain cancer triggers a strong immune response
News Nation: Researchers develop vaccine to fight brain cancer
The Gainesville Sun: UF Health scientists make breakthrough in possible cancer treatment
The Independent: New mRNA cancer vaccine triggers immune system to fight aggressive brain tumour
The Times: ‘Fierce immune response’ from vaccine offers hope for glioblastoma
U.S. News & World Report: mRNA vaccine fights deadly brain tumor in small trial